Molecular determinants for virulence in coxsackievirus B1 infection

Journal of Virology

Volumn 71, Issue 5, 1997, Pages 3986-3991

  Rinehart, Janet E ^a   Gómez, Ricardo M ^a   Roos, Raymond P ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RNA STRUCTURE; VIRUS INFECTION; VIRUS VIRULENCE;

EID: 1842375626     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.3986-3991.1997     Document Type: Article

References (32)

1. Auvinen, P., G. Stanway, and T. Hyypiä. 1989. Genetic diversity of enterovirus subgroups. Arch. Virol. 104:175-186.
2. Cammack, N., A. Phillips, G. Dunn, V. Patel, and P. D. Minor. 1988. Intertypic genomic rearrangements of poliovirus strains in vaccinees. Virology 167:507-514.
3. Chapman, N. M., S. Tracy, C. J. Gauntt, and U. Fortmueller. 1990. Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization. J. Clin. Microbiol. 28:843-850.
4. Diedrich, S., G. Driesel, and E. Schreier. 1995. Sequence comparison of echovirus type 30 isolates to other enteroviruses in the 5′ noncoding region. J. Med. Virol. 46:148-152.
5. Ehrenfeld, E. 1996. Initiation of translation by picornavirus RNAs, p. 549-573. In J. W. B. Hershey, M. B. Mathews, and N. Sonenberg (ed.), Translational control. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
6. Evans, D. M. A., G. Dunn, P. D. Minor, G. C. Schild, A. J. Cann, G. Stanway, J. W. Almond, K. Currey, and J. V. Maizel. 1985. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 314:548-550.
7. Furione, M., S. Guillot, D. Otelea, J. Balanant, A. Candrea, and R. Crainic. 1993. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 196:199-208.
8. Georgescu, M.-M., F. Delpeyroux, and R. Crainic. 1995. Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus. J. Gen. Virol. 76:2343-2348.
9. Huttunen, P., J. Santti, T. Pulli, and T. Hyypiä. 1996. The major echovirus group is genetically coherent and related to coxsackie B viruses. J. Gen. Virol. 77:715-725.
10. Iizuka, N., S. Kuge, and A. Nomoto. 1987. Complete nucleotide sequence of the genome of coxsackievirus B1. Virology 156:64-73.
11. Iizuka, N., H. Yonekawa, and A. Nomoto. 1991. Nucleotide sequences important for translation initiation of enterovirus RNA. J. Virol. 65:4867-4873.
12. Jackson, R. J., and A. Kaminski. 1995. Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond. RNA 1:985-1000.
13. Jakob, J., and R. P. Roos. 1996. Molecular determinants of Theiler's murine encephalomyelitis-induced disease. J. NeuroVirol. 2:70-77.
14. Jang, S. K., T. V. Pestova, C. U. T. Hellen, G. W. Witherell, and E. Wimmer. 1990. Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site. Enzyme 44:292-309.
15. Kawamura, N., M. Kohara, S. Abe, T. Komatsu, K. Tago, M. Arita, and A. Nomoto. 1989. Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attentuation phenotype. J. Virol. 63:1302-1309.
16. Kirkegaard, K., and D. Baltimore. 1986. The mechanism of RNA recombination in poliovirus. Cell 47:433-443.
17. Kong, W.-P., G. D. Ghadge, and R. P. Roos. 1994. Involvement of cardiovirus leader in host cell-restricted virus expression. Proc. Natl. Acad. Sci. USA 91:1796-1800.
18. La Monica, N., C. Meriam, and V. R. Racaniello. 1986. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J. Virol. 57:015-525.
19. Melnick, J. L. 1985. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p. 739-794. In B. N. Fields (ed.), Virology. Raven Press, New York, N.Y.
20. Minnich, L. L., and C. G. Ray. 1980. Variable susceptibility of mice to group B coxsackievirus infections. J. Clin. Microbiol. 11:73-75.
21. Pelletier, J., G. Kaplan, V. R. Racaniello, and N. Sonenberg. 1988. Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5′ noncoding region. Mol. Cell. Biol. 8:1103-1112.
22. Ray, C. G., L. L. Minnich, and P. C. Johnson. 1979. Selective polymyositis induced by coxsackievirus B1 in mice. J. Infect. Dis. 140:239-243.
23. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
24. Roos, R. P., S. Stein, Y. Ohara, J. Fu, and B. L. Semler. 1989. Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J. Virol. 63:5492-5496.
25. Semler, B. L., V. H. Johnson, and S. Tracy. 1986. A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperature-sensitive. Proc. Natl. Acad. Sci. USA 83:1777-1781.
26. Strongwater, S. I., K. Dorozini-Zis, R. D. Ball, and T. J. Schnitzer. 1984. A murine model of polymyositis induced by coxsackievirus B1 (Tucson strain). Arthritis Rheum. 27:433-442.
27. Svitkin, Y. V., S. V. Maslova, and V. I. Agol. 1985. The genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies. Virology 147:243-252.
28. Tolskaya, E. A., L. I. Romanova, V. M. Blinov, E. G. Viktorova, A. N. Sinyakov, M. S. Kolesnikova, and V. I. Agol. 1987. Studies on the recombination between RNA genomes of poliovirus: the primary structure and nonrandom distribution of crossover regions in the genomes of intertypic poliovirus recombinants. Virology 161:54-61.
29. Toniolo, A., T. Onodera, G. Jordan, J.-W. Yoon, and A. L. Notkins. 1982. Virus-induced diabetes mellitus glucose abnormalities produced in mice by the six members of the coxsackie B virus group. Diabetes 31:496-499.
30. Tu, Z., N. M. Chapman, G. Hufnagel, S. Tracy, J. R. Romero, W. H. Barry, L. Zhao, K. Currey, and B. Shapiro. 1995. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ nontranslated region. J. Virol 69:4607-4618.
31. Zhang, G., G. Wilsden, N. J. Knowles, and J. W. McCauley. 1993. Complete nucleotide sequence of a coxsackievirus B5 virus and its relationship to swine vesicular disease virus. J. Gen. Virol. 74:845-853.
32. Zoll, J., J. Galama, and W. Melchers. 1994. Intratypic variability of the coxsackievirus B1 2A protease region. J. Gen. Virol. 75:687-692.